ANALYST-UPGRADE ·Filed Oct 1, 2026
Argus Research double upgrade: Hold → Buy
Price Chart
Loading chart...
Executive Summary
Argus Research double upgrade: Hold → Buy
Impact Score
Base Score
2/7
LLM Adjustment
+0
Final Score
4/10
Consensus & Targets
Buy / Strong Buy
26 (68%)
Hold
12
Sell / Strong Sell
0
Total Analysts
26
Mean PT
$850.88
Median PT
$857.00
High PT
$1,030.00
Low PT
$730.00
Current Price
$758.27
Implied Upside
+12.2%
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-10-01 | Argus Research | upgrade | Buy | $850.00 |
| 2026-09-29 | RBC Capital | reiterate | Sector Perform | $737.00 |
| 2026-09-10 | HSBC | maintain | Buy | $920.00 |
| 2026-08-17 | Leerink Partners | maintain | Market Perform | $824.00 |
| 2026-08-03 | Citigroup | maintain | Neutral | — |
| 2026-08-03 | Guggenheim | maintain | Buy | $1,030.00 |
| 2026-07-31 | RBC Capital | maintain | Sector Perform | $737.00 |
| 2026-07-31 | Morgan Stanley | maintain | Equal-Weight | $758.00 |
| 2026-07-31 | Cantor Fitzgerald | maintain | Overweight | $795.00 |
| 2026-07-31 | Wells Fargo | maintain | Equal-Weight | $750.00 |
Firm Track Record — Argus Research
Argus Research accuracy: 54% on 339 calls | avg return: 3.7%
Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 15 firms with ≥5 scored calls.
| Firm | Accuracy | Calls | Avg Return | vs Average |
|---|---|---|---|---|
| UBS | 67% | 4/6 | 5.1% | top tier |
| Canaccord Genuity | 57% | 4/7 | 9.4% | above average |
| TD Cowen | 50% | 1/2 | 3.1% | below average |
| Bernstein | 50% | 1/2 | 6.2% | below average |
| Cantor Fitzgerald | 50% | 4/8 | -4.5% | below average |
| BMO Capital | 50% | 3/6 | -3.7% | below average |
| Morgan Stanley | 50% | 5/10 | 4.1% | below average |
| Goldman Sachs | 50% | 1/2 | -3.6% | below average |
| Leerink Partners | 50% | 1/2 | -23.7% | below average |
| Evercore ISI Group | 50% | 1/2 | -4.9% | below average |
Earnings Estimates
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| +1q | $15.53 | $10.47 — $18.62 | $4.6B | ↑0 ↓0 |
| 0q | $15.94 | $14.53 — $17.68 | $4.5B | ↑0 ↓0 |
| 0y | $54.10 | $43.42 — $59.45 | $17.0B | ↑2 ↓0 |
| +1y | $50.63 | $42.52 — $57.25 | $18.5B | ↑0 ↓0 |
Cross-Platform Signals
Insider Trades (90d)
0 buys / 5 sells
Congressional
Ro Khanna (democrat) — buy $1,001 - $15,000
Institutional
MANUFACTURERS LIFE INSURANCE COMPANY, THE — trim (-63.8%)
Institutional
Integrated Wealth Concepts LLC — trim (-45.3%)
Institutional
Allianz Asset Management GmbH — add (26.4%)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
Report based on filing metadata.
26 reports for REGN
85% Hit rate best @ T+60▲ +26.47%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 1, 2026 1d ago | ANALYST-UPGRADE | — | awaiting T+20 | — | — |
Sep 3, 2026 29d ago | Insider Cluster | $843.47 $735.20 | ▼ −12.84% | ▼ −11.65% | $735.20 (−12.84%) |
Aug 24, 2026 5w ago | Court Ruling | $828.50 $803.90 | ▼ −2.97% | ▼ −4.28% | $735.20 (−11.26%) |
Aug 20, 2026 6w ago | Press Release | $826.64 $784.85 | ▼ −5.06% | ▼ −5.06% | $735.20 (−11.06%) |
Aug 12, 2026 7w ago | Insider Cluster | $797.99 $793.26 | ▼ −0.59% | ▲ +1.30% | $735.20 (−7.87%) |
Aug 11, 2026 7w ago | Court Ruling | $797.00 $807.65 | ▲ +1.34% | ▲ +2.40% | $735.20 (−7.75%) |
Jul 30, 2026 9w ago | 8-K | $738.34 $807.71 | ▲ +9.40% | ▲ +5.43% | $735.20 (−0.43%) |
Jul 30, 2026 9w ago | Press Release | $738.34 $807.71 | ▲ +9.40% | ▲ +5.43% | $735.20 (−0.43%) |
Jul 27, 2026 9w ago | Press Release | $695.18 $833.56 | ▼ −19.91% | ▼ −16.52% | $735.20 (−5.76%) |
Jul 17, 2026 11w ago | Press Release | $676.69 $800.70 | ▲ +18.33% | ▲ +13.88% | $735.20 (+8.65%) |
Showing 10 of 26
US Market Status
Market Closed — Opens Mon (64h 22m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access